At the news
? NEUTRALIMPACT 3/10 8-K filed Aug 3, 2026 at 07:00 ET
Glaukos filed an 8-K furnishing an August 2026 investor presentation. The presentation reiterates previously disclosed 2026 revenue guidance of $690M, highlights 85% non-GAAP gross margin, $289M cash with no debt, and a strong pipeline including iDose TR and Epioxa. No new material financial information or guidance changes are introduced.
- 2026 revenue guidance midpoint of $690M, unchanged from 2Q 2026 earnings call on 7/29/2026
- 2Q 2026 non-GAAP gross margin of 85%
- Cash and equivalents of $289M with no debt as of 6/30/2026
- $900M invested in R&D since 2018
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access